B.G. and M.K.K. contributed equally to the study.
Trimethoprim–metformin interaction and its genetic modulation by OCT2 and MATE1 transporters
Version of Record online: 21 OCT 2013
© 2013 The Authors. British Journal of Clinical Pharmacology © 2013 The British Pharmacological Society
British Journal of Clinical Pharmacology
Volume 76, Issue 5, pages 787–796, November 2013
How to Cite
Grün, B., Kiessling, M. K., Burhenne, J., Riedel, K.-D., Weiss, J., Rauch, G., Haefeli, W. E. and Czock, D. (2013), Trimethoprim–metformin interaction and its genetic modulation by OCT2 and MATE1 transporters. British Journal of Clinical Pharmacology, 76: 787–796. doi: 10.1111/bcp.12079
Part of this work was presented in abstract form at the ASCPT 2012 Annual Meeting (National Harbor, MD, USA, 12–17 March).
- Issue online: 21 OCT 2013
- Version of Record online: 21 OCT 2013
- Accepted manuscript online: 11 JAN 2013 06:35AM EST
- Manuscript Accepted: 22 DEC 2012
- Manuscript Received: 30 MAY 2012
- Federal Ministry of Education and Research (BMBF). Grant Number: 01ET0718
Steady-state metformin pharmacokinetics after oral administration of 500 mg three times daily as monotherapy according to subgroup
Steady-state metformin pharmacokinetics after oral administration of 500 mg three times daily during cotreatment with trimethoprim according to subgroup
Biomarker during metformin monotherapy according to subgroup
Biomarker during cotreatment with trimethoprim according to subgroup
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.